Related Experiment Video
Updated: May 5, 2026

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
Insights into the Pathogenesis and Development of Recombinant Japanese Encephalitis Virus Genotype 3 as a Vaccine
Jae-Yeon Park1, Hye-Mi Lee1, Sung-Hoon Jun2
1College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea.
Abstract:
Japanese encephalitis virus (JEV), a flavivirus transmitted by mosquitoes, has caused epidemics and severe neurological diseases in Asian countries. In this study, we developed a cDNA infectious clone, pBAC JYJEV3, of the JEV genotype 3 strain (EF571853.1) using a bacterial artificial chromosome (BAC) vector. The constructed infectious clone was transfected into Vero cells, where it exhibited infectivity and induced cytopathic effects akin to those of the parent virus. Confocal microscopy confirmed the expression of the JEV envelope protein. Comparative analysis of growth kinetics revealed similar replication dynamics between the parental and recombinant viruses, with peak titers observed 72 h post-infection (hpi). Furthermore, plaque assays demonstrated comparable plaque sizes and morphologies between the viruses. Cryo-electron microscopy confirmed the production of recombinant virus particles with a morphology identical to that of the parent virus. Immunization studies in mice using inactivated parental and recombinant viruses revealed robust IgG responses, with neutralizing antibody production increasing over time. These results showcase the successful generation and characterization of a recombinant JEV3 virus and provide a platform for further investigations into JEV pathogenesis and vaccine development.
Insights
Researchers created a functional Japanese encephalitis virus (JEV) infectious clone, enabling new JEV pathogenesis and vaccine development studies. The recombinant virus showed infectivity and immune responses similar to the parent virus.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus causing epidemics and neurological disease in Asia.
- JEV genotype 3 poses a significant public health concern.
Purpose of the Study:
- To construct and characterize a cDNA infectious clone of JEV genotype 3.
- To provide a tool for studying JEV pathogenesis and developing vaccines.
Main Methods:
- Development of a bacterial artificial chromosome (BAC) based cDNA infectious clone (pBAC JYJEV3) of JEV genotype 3.
- Transfection into Vero cells, growth kinetics, plaque assays, cryo-electron microscopy, and mouse immunization studies.
Main Results:
- The infectious clone produced infectious JEV with similar replication, cytopathic effects, and particle morphology to the parent virus.
- Immunization with inactivated recombinant JEV induced robust IgG and neutralizing antibody responses in mice.
Conclusions:
- Successful generation of a recombinant JEV3 infectious clone.
- The clone serves as a valuable platform for JEV research, including pathogenesis and vaccine development.
Related Concept Videos
Vaccine Production
Arboviral Encephalitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology

